GSK, Pfiz­er present key dura­bil­i­ty da­ta for RSV shots, as CDC pan­el scru­ti­nizes ri­val vac­cines

GSK and Pfiz­er pro­vid­ed the first looks on Wednes­day at how long-last­ing pro­tec­tion from their res­pi­ra­to­ry syn­cy­tial virus vac­cines could be for old­er adults, pre­sent­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER